You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 4
  • EP1120 Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: outcomes from an Institutional series

Citation Tools

Article menu
Download PDFPDF
ePoster
EP1120 Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: outcomes from an Institutional series

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Falcone F, Normanno N, Losito N, et al
EP1120 Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: outcomes from an Institutional series
International Journal of Gynecologic Cancer 2019;29:A584.